Cargando…
Immuno-Isolation of Pancreatic Islet Allografts Using Pegylated Nanotherapy Leads to Long-Term Normoglycemia in Full MHC Mismatch Recipient Mice
Two major hurdles need to be surmounted for cell therapy for diabetes: (i) allo-immune rejection of grafted pancreatic islets, or stem/precursor cell-derived insulin-secreting cells; and (ii) continuing auto-immunity against the diabetogenic endogenous target antigen. Nanotherapeutics offer a novel...
Autores principales: | Dong, Huansheng, Fahmy, Tarek M., Metcalfe, Su M., Morton, Steve L., Dong, Xiao, Inverardi, Luca, Adams, David B., Gao, Wenda, Wang, Hongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515593/ https://www.ncbi.nlm.nih.gov/pubmed/23227162 http://dx.doi.org/10.1371/journal.pone.0050265 |
Ejemplares similares
-
Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers
por: Liu, Yang, et al.
Publicado: (2017) -
MHC Mismatch Inhibits Neurogenesis and Neuron Maturation in Stem Cell Allografts
por: Chen, Zhiguo, et al.
Publicado: (2011) -
Co-transplantation of pancreatic islets and microvascular fragments effectively restores normoglycemia in diabetic mice
por: Wrublewsky, Selina, et al.
Publicado: (2022) -
Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability
por: Burke, Jacqueline A., et al.
Publicado: (2022) -
RCAN-11R peptide provides immunosuppression for fully mismatched islet allografts in mice
por: Noguchi, Hirofumi, et al.
Publicado: (2017)